{
  "case_id": "Case_1",
  "model_id": "openai/gpt-oss-120b",
  "content": "{\n    \"primary_diagnosis\": {\n        \"name\": \"Familial Mediterranean fever (FMF)\",\n        \"confidence\": 0.78,\n        \"icd_code\": \"M04.1\",\n        \"reasoning\": \"Recurrent self\u2011limited episodes of serositis (severe abdominal pain with peritoneal signs), high fevers, and transient arthritis in a young adult of African descent, with similar episodes reported in family members, strongly suggest an autosomal recessive autoinflammatory syndrome such as FMF.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Hyper IgD syndrome (Mevalonate kinase deficiency)\",\n            \"confidence\": 0.45,\n            \"icd_code\": \"D80.1\",\n            \"reasoning\": \"Also presents with recurrent fevers, abdominal pain, and arthritis, but typically includes a rash and higher IgD levels; family history may be present.\"\n        },\n        {\n            \"name\": \"Crohn disease (Inflammatory bowel disease)\",\n            \"confidence\": 0.40,\n            \"icd_code\": \"K50.9\",\n            \"reasoning\": \"Can cause episodic abdominal pain, fever, and peripheral arthritis; however, episodes usually last longer and are not self\u2011limited within days.\"\n        },\n        {\n            \"name\": \"Autoinflammatory disease, unspecified (e.g., TRAPS)\",\n            \"confidence\": 0.30,\n            \"icd_code\": \"M04.9\",\n            \"reasoning\": \"Other hereditary periodic fever syndromes can mimic FMF with serositis and arthritis; lack of clear genetic data makes this a consideration.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Recurrent episodes of severe abdominal pain with peritoneal signs lasting 2\u20113 days\",\n        \"High fever spikes (up to 39.5\u00b0C) and transient arthritis of knees/ankles\",\n        \"Elevated CRP and ESR during attacks\",\n        \"Family history of similar episodic illness\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"MEFV gene mutation analysis (PCR/sequencing)\",\n            \"purpose\": \"To confirm FMF by identifying pathogenic variants\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Serum amyloid A (SAA) level\",\n            \"purpose\": \"Baseline for risk of amyloidosis and to monitor disease activity\",\n            \"priority\": \"routine\"\n        },\n        {\n            \"test\": \"Abdominal ultrasound or CT abdomen\",\n            \"purpose\": \"Rule out alternative intra\u2011abdominal pathology (e.g., appendicitis, TB peritonitis)\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Complete blood count, comprehensive metabolic panel\",\n            \"purpose\": \"Assess for anemia, renal/hepatic function before colchicine\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Colonoscopy with ileal intubation if IBD suspected\",\n            \"purpose\": \"Evaluate for Crohn disease if symptoms persist or imaging suggests bowel pathology\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Start colchicine 0.6\u202fmg orally twice daily (adjust for weight and renal function)\",\n            \"Provide intravenous fluids and analgesia (e.g., IV morphine) for acute pain control\",\n            \"Obtain blood cultures if fever >38.5\u00b0C persists >24\u202fh to exclude infection\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Colchicine\",\n                \"dose\": \"0.6\u202fmg PO twice daily (may increase to 1.2\u202fmg BID if tolerated)\",\n                \"route\": \"PO\",\n                \"duration\": \"Long\u2011term maintenance\",\n                \"rationale\": \"First\u2011line therapy for FMF; reduces attack frequency and prevents amyloidosis\"\n            },\n            {\n                \"drug\": \"Ibuprofen\",\n                \"dose\": \"600\u202fmg PO every 6\u202fh as needed for pain\",\n                \"route\": \"PO\",\n                \"duration\": \"During acute attacks\",\n                \"rationale\": \"NSAID for additional analgesia and anti\u2011inflammatory effect\"\n            }\n        ],\n        \"monitoring\": [\n            \"CRP, ESR, and SAA weekly for the first month then monthly\",\n            \"Renal and hepatic function tests every 3\u202fmonths while on colchicine\",\n            \"Signs of colchicine toxicity (GI upset, myopathy, cytopenias)\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Rheumatology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"Confirm diagnosis, guide colchicine dosing, consider IL\u20111 inhibitor if colchicine\u2011resistant\"\n            },\n            {\n                \"specialty\": \"Medical Genetics\",\n                \"urgency\": \"routine\",\n                \"reason\": \"Counseling regarding hereditary nature and family screening\"\n            },\n            {\n                \"specialty\": \"Interpreter services (Somali)\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"Ensure accurate communication for history, education, and consent\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Persistent fever >5\u202fdays or worsening abdominal signs suggesting perforation or sepsis\",\n        \"New onset renal insufficiency or proteinuria (possible amyloidosis)\",\n        \"Severe abdominal distension, hypotension, or signs of peritonitis requiring surgical evaluation\"\n    ],\n    \"patient_education\": [\n        \"Explain FMF as a genetic autoinflammatory condition and the importance of daily colchicine to prevent attacks and long\u2011term complications.\",\n        \"Discuss potential side effects of colchicine and the need to report gastrointestinal upset, muscle pain, or unusual bruising.\",\n        \"Provide information on genetic counseling for family members and the possibility of carrier testing.\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Rheumatology appointment within 1\u202fweek; primary care follow\u2011up in 2\u202fweeks after discharge\",\n       ",
  "latency": 9.649958848953247,
  "timestamp": "2025-08-10T00:22:45.949632",
  "cached_at": "2025-08-10T00:22:45.949639"
}